2929 Stock Overview
Engages in the development and sale of functional food ingredients in Japan. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 2929 from our risk checks.
Pharma Foods International Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥955.00 |
52 Week High | JP¥1,371.00 |
52 Week Low | JP¥800.00 |
Beta | 1.35 |
11 Month Change | 11.70% |
3 Month Change | -4.31% |
1 Year Change | -28.09% |
33 Year Change | -63.44% |
5 Year Change | 95.30% |
Change since IPO | 44.70% |
Recent News & Updates
Recent updates
Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares
Oct 31We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated
Sep 22Is Pharma Foods International (TSE:2929) Using Too Much Debt?
Jul 23We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit
Mar 23Shareholder Returns
2929 | JP Biotechs | JP Market | |
---|---|---|---|
7D | -4.0% | -8.0% | -1.2% |
1Y | -28.1% | 13.5% | 12.3% |
Return vs Industry: 2929 underperformed the JP Biotechs industry which returned 13.5% over the past year.
Return vs Market: 2929 underperformed the JP Market which returned 12.3% over the past year.
Price Volatility
2929 volatility | |
---|---|
2929 Average Weekly Movement | 5.2% |
Biotechs Industry Average Movement | 8.3% |
Market Average Movement | 3.8% |
10% most volatile stocks in JP Market | 7.7% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2929 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2929's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 642 | Yongsook Kim | www.pharmafoods.co.jp |
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody, and peptide and diagnostics. Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd. Fundamentals Summary
2929 fundamental statistics | |
---|---|
Market cap | JP¥27.57b |
Earnings (TTM) | JP¥3.21b |
Revenue (TTM) | JP¥62.15b |
8.4x
P/E Ratio0.4x
P/S RatioIs 2929 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2929 income statement (TTM) | |
---|---|
Revenue | JP¥62.15b |
Cost of Revenue | JP¥13.40b |
Gross Profit | JP¥48.75b |
Other Expenses | JP¥45.55b |
Earnings | JP¥3.21b |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Dec 11, 2024
Earnings per share (EPS) | 114.17 |
Gross Margin | 78.45% |
Net Profit Margin | 5.16% |
Debt/Equity Ratio | 145.8% |
How did 2929 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield22%
Payout RatioDoes 2929 pay a reliable dividends?
See 2929 dividend history and benchmarksPharma Foods International dividend dates | |
---|---|
Ex Dividend Date | Jan 30 2025 |
Dividend Pay Date | Apr 02 2025 |
Days until Ex dividend | 71 days |
Days until Dividend pay date | 133 days |
Does 2929 pay a reliable dividends?
See 2929 dividend history and benchmarks